Yuya Yoshimoto

Fukushima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Real-world treatment patterns and survival in advanced/metastatic triple-negative breast cancer in Japan.

Real-world treatment patterns and survival in advanced/metastatic triple-negative breast cancer in Japan.

Journal: Expert review of anticancer therapy

Published: May 18, 2026

1064 nm-absorbing semiconducting polymer nanoparticles for multimodal photoacoustic and fluorescence imaging.

1064 nm-absorbing semiconducting polymer nanoparticles for multimodal photoacoustic and fluorescence imaging.

Journal: Biomedical optics express

Published: May 11, 2026

Clinical efficacy of anti-PD-1 immunotherapy with localized non-ablative irradiation against metastatic lymph node in patients with metastatic gastric cancer.

Clinical efficacy of anti-PD-1 immunotherapy with localized non-ablative irradiation against metastatic lymph node in patients with metastatic gastric cancer.

Journal: Clinical and translational radiation oncology

Published: March 09, 2026

MYC upregulation as candidate predictive biomarker for radioresistance in cervical cancer.

MYC upregulation as candidate predictive biomarker for radioresistance in cervical cancer.

Journal: Japanese journal of radiology

Published: February 11, 2026

Nivolumab in combination with radiotherapy for unresectable advanced or recurrent gastric cancer (CIRCUIT trial): A 5-year update of the progression-free survival and local control outcomes.

Nivolumab in combination with radiotherapy for unresectable advanced or recurrent gastric cancer (CIRCUIT trial): A 5-year update of the progression-free survival and local control outcomes.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 23, 2025

Treatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan.

Treatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan.

Journal: Future oncology (London, England)

Published: February 02, 2024

Combination of oligo-fractionated irradiation with nivolumab can induce immune modulation in gastric cancer.

Combination of oligo-fractionated irradiation with nivolumab can induce immune modulation in gastric cancer.

Journal: Journal for immunotherapy of cancer

Published: January 16, 2024

Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma.

Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma.

Journal: Anticancer research

Published: July 29, 2023

Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).

Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).

Journal: Cytotherapy

Published: March 15, 2023

Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer.

Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer.

Journal: Communications medicine

Published: March 07, 2023

CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma.

CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma.

Journal: Anticancer research

Published: February 08, 2023

Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis.

Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis.

Journal: Cancer reports (Hoboken, N.J.)

Published: January 16, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026